Clinical Trial Update: 'SOURCE - LUNG' Stereotactic Ablative Radiation Therapy Of UltRaCEntral LUNG Tumours (SOURCE Lung) [Phase 2]

View source ↗

Summary

A Phase 2 trial (SOURCE Lung) evaluating stereotactic ablative radiotherapy for ultracentral lung tumors, including non-small cell lung cancer and oligometastat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Cancer Trials Ireland | Conditions: NSCLC/Oligometastatic Cancer (Single Lung Lesion) | Phase 2 | Status: RECRUITING